Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Barba

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Frontiers in Plant Science|April 26, 2017
Insights on Structure and Function of a Late Embryogenesis Abundant Protein from <i>Amaranthus cruentus</i>: An Intrinsically Disordered Protein Involved in Protection against Desiccation, Oxidant Conditions, and Osmotic StressAlma L Saucedo, Eric E Hernández-Domínguez, Luis A de Luna-Valdez, et al.
Bone Marrow Transplantation|December 11, 2012
Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow TransplantationS Cesaro, M Pillon, G Tridello, et al.
Bone Marrow Transplantation|January 13, 2015
Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximabI García-Cadenas, N Castillo, R Martino, et al.
Journal of Cancer Research and Clinical Oncology|November 29, 2011
Hox B4 as potential marker of non-differentiated cells in human cervical cancer cellsAna P Barba-de la Rosa, Erika Briones-Cerecero, Ofelia Lugo-Melchor, et al.
Bone Marrow Transplantation|October 14, 2014
GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCTR Parody, L Lopez-Corral, O L Godino, et al.
Bone Marrow Transplantation|September 16, 2014
Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilizationI Sánchez-Ortega, S Querol, M Encuentra, et al.
Bone Marrow Transplantation|June 14, 2016
GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter studyR Parody, L López-Corral, O Lopez-Godino, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 6, 2015
Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH)R Martino, G Bautista, R Parody, et al.
Bone Marrow Transplantation|November 8, 2016
Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantationM A Kharfan-Dabaja, R Parody, J Perkins, et al.
Bone Marrow Transplantation|October 10, 2017
Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysisC Cho, M Hsu, P Barba, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Frontiers in Plant Science|April 26, 2017
Insights on Structure and Function of a Late Embryogenesis Abundant Protein from <i>Amaranthus cruentus</i>: An Intrinsically Disordered Protein Involved in Protection against Desiccation, Oxidant Conditions, and Osmotic StressAlma L Saucedo, Eric E Hernández-Domínguez, Luis A de Luna-Valdez, et al.
Bone Marrow Transplantation|December 11, 2012
Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow TransplantationS Cesaro, M Pillon, G Tridello, et al.
Bone Marrow Transplantation|January 13, 2015
Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximabI García-Cadenas, N Castillo, R Martino, et al.
Journal of Cancer Research and Clinical Oncology|November 29, 2011
Hox B4 as potential marker of non-differentiated cells in human cervical cancer cellsAna P Barba-de la Rosa, Erika Briones-Cerecero, Ofelia Lugo-Melchor, et al.
Bone Marrow Transplantation|October 14, 2014
GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCTR Parody, L Lopez-Corral, O L Godino, et al.
Bone Marrow Transplantation|September 16, 2014
Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilizationI Sánchez-Ortega, S Querol, M Encuentra, et al.
Bone Marrow Transplantation|June 14, 2016
GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter studyR Parody, L López-Corral, O Lopez-Godino, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 6, 2015
Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH)R Martino, G Bautista, R Parody, et al.
Bone Marrow Transplantation|November 8, 2016
Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantationM A Kharfan-Dabaja, R Parody, J Perkins, et al.
Bone Marrow Transplantation|October 10, 2017
Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysisC Cho, M Hsu, P Barba, et al.
Pageof 11